Skip to main content
Premium Trial:

Request an Annual Quote

Jon Faiz Kayyem

GenMark Diagnostics' Founder Jon Faiz Kayyem is transitioning from his position as head of R&D to become a technical and strategic advisor to its management team and board of directors. Kayyem is the inventor of the firm's eSensor electronic detection technology and led the development of its ePlex multiplex platform. Kayyem noted during a company presentation Tuesday that he will now "endeavor to add value in new ways beyond ePlex."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.